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Background. WATSU (WaterShiatsu) is a complementary therapeutic treatment method comprising passive stretches and massage
techniques administered in 35∘C warm water. Pregnant women claim safe methods to reduce pain, stress, and fatigue. Therefore,
we conducted a pilot study evaluating the effects of WATSU on pregnancy-related complaints in third trimester pregnant women.
Methods. Nine healthy pregnant women at gestational week ≥34 were included in an intervention group (receiving WATSU) and
compared to eight women in a passive control group (receiving no treatment). WATSU was performed on days 1 and 4 of the
study, accompanied by ultrasound examinations. Outcomes include physiological and psychometric as well as qualitative data.
Participants in the control group completed questionnaires only. Results. WATSU was found to significantly lower participants’
levels of stress and pain and to improve their mental health-related quality of life and mood. In comparison to the passive control
group, participants in the intervention group reported reduction in perceived stress from day 1 to day 8 (𝑃 = 0.036, Cohen’s
𝑓 = 0.57). Qualitative data indicate that WATSU was appreciated as enjoyable and deeply relaxing. No negative side effects were
reported. Conclusion. Our findings support the notion that WATSU yields therapeutic benefits for pregnant women and warrant
further research. This study has been registered at ClinicalTrials.gov: NCT01708018.
1. Introduction
Several researchers propose that, during pregnancy, maternal
mental and physical wellbeing are transferred to the fetus
resulting in epigenetic changes implicating consequences for
a lifetime [1–4]. Hence, with respect to the child’s future
development, severe maternal stress and distress cannot be
considered to be of transient nature [5]. Moreover, maternal
effect and attitude during pregnancy are also predictive fac-
tors for postnatal depressive symptoms [6], which in turn are
likely to affect the child’s wellbeing.
WATSU (an acronym based on WAter and shiaTSU) is a
body-based method [7] comprising buoyancy, passive stre-
tches, and massage techniques, including massage and pal-
pation of acupuncture points that is administered in warm
water. WATSU has been described as applicable during
pregnancy [8], where it is claimed to reduce pregnancy-
related low back pain, to relax hypertonic muscles including
those of the uterus, to improve the overall sense of wellbeing,
and to deepen the relationship of themother with her unborn
child.
In the 1980s, WATSU was created by massage-therapist
HaroldDull, whose personal affinity to water led him to prac-
tice Masunaga-Shiatsu (also known as Zen-Shiatsu) in water
heated to roughly skin temperature (308.15 Kelvin; 35∘C,
95∘F). He used Shiatsu massage of acupuncture points, joint
mobilization, and tissue stretches and added gentle massage
techniques to harmonize the energy flow (qi,氣) according to
the principles of Traditional Chinese Medicine (TCM), from
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which Shiatsu originates [9]. The increased clinical imple-
mentation of WATSU in interdisciplinary treatment settings
such as rehabilitation facilities indicates a growing acceptance
of this body-based complementary therapeutic intervention;
it is used as a component in multimodal treatment settings
focusing on posttraumatic stress disorder, and anxiety [10, 11],
chronic pain and fibromyalgia [11, 12], stress-related illnesses
[13], depression [11, 14], and sexual dysfunction [15]. WATSU
has also been recommended as a treatment for patients with
hemiparesis,multiple sclerosis, cerebral palsy, and spinal cord
injury [16, 17]. Considering physiological effects on the car-
diopulmonary system due to physical exposure to hydrostatic
pressure, certain cardiac conditions, for example, chronic
heart failure [18] and respiratory impairments such as cystic
fibrosis [19] can be regarded as potential indications for this
treatment.
However, clinical trials investigating therapeutic effects of
WATSU are still scarce. To our knowledge, to date, only three
small scale trials onWATSU have been published [12, 16, 20].
Regarding pregnancy, gymnastics in water were observed
to have pain-relieving effects [21, 22], as were massage [23]
and birth in water [24]. Active hydrotherapy during preg-
nancy is considered to be beneficial and safe [25], while the
effects of passive hydrotherapy during pregnancy so far have
not been the subject of scientific investigation. Therefore, we
designed a pilot study to examine safety of WATSU as well
as a broad range of issues to identify those worthwhile pur-
suing in future research, that is, potential therapeutic effects
of WATSU on self-reported stress, pregnancy-related pain,
mood and quality of life, amount of amniotic fluid, blood flow
characteristics, spontaneous course of breech presentations,
and prospects of external cephalic versions in third trimester
pregnant women. Additionally, qualitative data reflecting
participants’ perception of the interventionwere assessed and
analyzed.
2. Methods
2.1. Study Design. We conducted a controlled clinical pilot
study at the Department of Obstetrics and Gynecology at
Bern University Hospital investigating the effects of WATSU
on pregnant women with pregnancy-related complaints at
week ≥34 of gestation. The research protocol was formally
approved by the Ethics Committee of the Canton of Bern,
Switzerland, and carried out according to the Helsinki Dec-
laration. Recruitment was carried out fromMay 2012 to May
2014 by medical staff at Bern University Hospital, as well as
through advertisements via the midwifery association of the
Canton of Bern. Potential participants were provided with
complete written and verbal information about the study and
written consent was obtained prior to participation. Inter-
ested healthy women with a singleton pregnancy in the 34th
or greater week of gestation underwent a telephone-
screening. Exclusion criteria were any pathological findings
during pregnancy, neurological deficits resulting from low
back pain,WATSU-treatment within the past four weeks, and
poor language skills. Women reporting a breech presentation
were included in the study if they did not plan external cer-
vical version. Participants in the intervention group received
standardized WATSU treatments at days 1 and 4, accompa-
nied by ultrasound examinations before and after WATSU
treatment and onday 8. Participantswere allocated to the pas-
sive control group if they refused to undergo intervention or
ultrasound examinations, or if they lived too far from the site
of the intervention. If allocated to the passive control group,
participants did receive neither WATSU nor any alternative
treatment on the part of the study. All participants were free
tomaintain additionalmedical and/or therapeutic treatments
during the study. Assessments took place on days 1 (baseline),
4, and 8 (follow-up). Participants were not financially com-
pensated; participants in the control groupwere offered a free
WATSU-treatment after study completion.
The study has been registered at ClinicalTrials.gov:
NCT01708018.
2.2. Intervention. WATSU treatments were performed by
four specialized therapists with ten to sixteen years of pro-
fessional experience and certification by the Swiss Aquatic
Bodywork Association (Netzwerk fu¨r Aquatische Ko¨rper-
arbeit (NAKA)). Each participant in the intervention group
received a standardized WATSU-treatment on the first and
fourth day of study participation, administered by the same
therapist. Participants were free to choose a female or a male
therapist. Sessions lasted 60 minutes and took place in the
morning from 9:00 a.m. to 10:00 a.m. in a therapy pool
located at the University Hospital of Bern filled with 35∘C
fresh water. The administered motion sequence “WATSU-
Transition-Flow” [9] was adapted for women in their third
trimester of pregnancy and was followed closely. During
the WATSU-treatment, participants’ abdomens were not
touched. Deviations from the standardized treatment proto-
colwere documented for each treatment session. Each session
started with a brief verbal description of the procedure and
ended with the opportunity for the client to give verbal
feedback. During WATSU treatment, participants rested in a
supine position, predominantly being supported at the back
of their head and at their pelvis or knees by their therapist’s
forearms. To unburden participants’ lower backs, floating
devices were attached to their thighs. In the course of treat-
ment, therapist and participant were in continuous physical
contact with distances varying from a full arm’s length to
cradled positions. The participant was slowly floated back
and forth through the water in large circular patterns, gener-
ated by the therapist’s rotation around her/his own body axis.
Following the session, participants were asked to drink
500mL of water to compensate for body fluid loss due to
increased diuresis [26, 27]. If indicated and with participants’
consent, external cephalic version (ECV) was performed on
day 9 of the study. Participants in the passive control group
received neither WATSU nor an alternative treatment in the
context of this trial.
2.3. OutcomeMeasures. Sociodemographic data (age, height,
weight, prior deliveries, week of gestation, and fetal position)
and baseline data (perceived stress, pain, and quality of life)
were assessed on day 1.
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2.3.1. Baseline Assessment on Day 1 and Follow-Up Assessment
on Day 8. Included the Perceived Stress Scale (PSS) and
theMedical Outcomes Study 36-Item Short Form Health
Survey (SF-36). Both questionnaires referred to participants’
self-reported condition in the past week.
Perceived Stress Scale (PSS). This 10-item questionnaire
assesses participants’ cognitive evaluation of stress perception
[28]. Participants estimate how unpredictable, uncontrol-
lable, and overloaded they perceive their lives to be on a
5-point scale ranging from “never” to “very often.” Good
internal consistency is reported (Cronbach’s 𝛼 = 0.87) [29].
Medical Outcomes Study 36-Item Short Form Health Survey
(SF-36). Health-related quality of life was assessed using a
questionnaire comprising eight subscales: “physical function-
ing,” “role physical,” “bodily pain,” “role emotional,” “vitality,”
“mental health,” “general health perception,” and “social func-
tioning.” The SF-36 shows good internal consistencies with
Cronbach’s 𝛼 > 0.70 in all subscales except “general health
perception” (0.57) and “social functioning” (0.69) [30].
2.3.2. Psychometric Assessment on Days 1 and 4 Immedi-
ately before and after WATSU Treatments. Included Visual
Analogue Scales (VAS) assessing pain and stress and the
Multidimensional Mood Questionnaire (MDMQ). These
instruments referred to participants’ self-reported actual
condition.
Stress and Pain Related Visual Analogue Scales (VAS). Visual
Analogue Scales have a length of 100mm, with 0mm indicat-
ing no stress, respectively, no pain at all, and 100mm repre-
senting maximal perception of stress, respectively, high pain.
VAS scales proved to be valid and reliable [31, 32].
Multidimensional Mood Questionnaire (MDMQ). The vali-
dated mood questionnaire with good internal consistencies
(Cronbach’s 𝛼 between 0.73 and 0.89) assesses treatment-
related changes in self-reportedmood. It consists of a list of 12
adjectives that address currentmood, calmness, and alertness
(e.g., “happy,” “nervous,” and “awake”) ranked on a 5-point
scale ranging from “not at all” to “very much.”The sum score
ranges from 12 to 60 with higher scores indicating better
mood [33].
2.3.3. Ultrasound Examination. All ultrasound examinations
were carried out twenty minutes before and after WATSU
treatment, as well as in the morning of day 8 by gynecologists
usingVolusonE8Expert, GEMedical Systems (Zipf, Austria),
with curved array transducer of 5–8MHz. Ultrasound mea-
surements included examination of fetal position and assess-
ment of amniotic fluid volume, measuring the single deepest
amniotic fluid pocket (SDP) [34, 35]. Doppler examination of
the umbilical artery and both uterine arteries was performed.
Blood flow characteristics were assessed measuring the pul-
satility index (PI). Along with this assessment, the tonus of
the uterus was palpated by the examining gynecologist.
2.3.4. Qualitative Outcome Measures. Participants in the
intervention group were asked to fill out a qualitative ques-
tionnaire answering the following questions right after their
second WATSU-treatment: “How was your experience being
treated with WATSU?” “Which changes did you notice in
response to yourWATSU treatment?” “Which aspects of your
WATSU treatment were less pleasant for you?” and “Do you
have any suggestions for improvement?”
2.4. Data Analysis. Quantitative data were analyzed based
on intention to treat. For missing data, the last value was
carried forward. Quantitative data analyses were conducted
using SPSS (version 19) statistical software package for
Windows (IBM SPSS Statistics, Somers, NY, USA). Prior
to statistical analyses, all data were tested for homogeneity
of variance and normal distribution employing Levene and
Kolmogorov-Smirnov tests. Between-group differences in
sociodemographic characteristics, baseline values, and mean
change values of outcome measures from baseline to follow-
up assessment were analyzed using Mann-Whitney𝑈 test for
continuous data, while the evaluation of categorical data was
based on visual inspection. Analyses of outcome measures
within the intervention group were performed using
Wilcoxon test. All analyses were two tailed, with the level
of significance set at 𝑃 < 0.05 with 95% confidence interval.
All continuous data are presented as mean value ± stand-
ard deviation (SD). For the purpose of international com-
parability, outcome values of the SF-36 main scales were
standardized by employing the weighting coefficient for US
population and transformed into percentages [30]. Effect size
parameters (𝑓) were derived from partial 𝜂2 values and were
reported based on the following effect size conventions: 𝑓:
0.10 = small, 0.25 = medium, and 0.40 = large [36].
Narrative questionnaire data reflecting participants’
experiences with WATSU were systematically organized
into analytical units, which were inductively classified into
thematic subcategories and main categories according to the
Mayring-triangulation-model [37]. All generated categories
were quantitatively described by indicating frequency of
mentions in absolute and percentage values. Qualitative
data reflecting context-related information were narratively
summarized.
3. Results
Seventeen of the 26 recruitedwomenwere includedwith nine
participants being allocated to the intervention group and
eight to the control group. Three participants in the control
group were lost to follow-up (for details see Figure 1). Finally,
data from all seventeen study participants were analyzed
according to the intention-to-treat principle. No adverse
events were reported, and all of the WATSU-treatments were
carried out as scheduled.
Group and baseline characteristics did not differ signifi-
cantly between the two study groups (see Table 1). Study par-
ticipants were between 27 and 40 years of age (32.0±3.2) and
69% of them were primiparous.
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Enrolled in study n = 17
Assessed for eligibility n = 26
Not included in study n = 9
3 schedule conﬂicts
2 poor language skills
3 premature birth
1 medical reasons
Control group n = 8
2 breech and low back pain
4 low back pain
2 no breech and no low back pain
Intervention group n = 9
4 breech and low back pain
4 breech
1 low back pain
Completed study n = 14
Analyzed per in intention-to-treat n = 17
Dropouts during data collection n = 3
3 lost interest in study participation
Figure 1: Consort flow diagram.
Table 1: Group and baseline characteristics.
Characteristicsa Intervention group (𝑛 = 9) Control group (𝑛 = 8) Complete sample (𝑛 = 17) 𝑃b
Age (years) 31.3 (±2.7) 32.8 (±3.7) 32.0 (±3.2) 0.56
BMI (kg/m2) 27.5 (±3.4) 25.5 (±2.3) 26.6 (±3.1) 0.31
Primiparous (yes/no) 6/3 7/1 13/4 n/a
Week of gestation 36.3 (±0.7) 35.8 (±1.2) 36.1 (±1.0) 0.43
Breech presentation (yes/no) 8/1 2/6 9/8 n/a
PSS score 14.8 (±5.0) 14.8 (±11.7) 14.8 (±8.5) 0.81
SF-36 main scales
(i) physical component 47.0 (±6.8) 40.4 (±10.7) 43.9 (±9.2) 0.18
(ii) mental component 46.4 (±11.6) 52.8 (±6.9) 49.4 (±9.9) 0.12
aAll continuous data are presented as mean (±SD).
b
𝑃 values refer to Mann-Whitney 𝑈 test.
n/a, not applicable; BMI, body mass index; PSS, Perceived Stress Scale; SF-36, Medical Outcomes Study 36-Item Short-Form Health Survey.
3.1. Quantitative Results. As presented in Table 2, analyses
within the intervention group revealed a significant improve-
ment in mental health-related quality of life (SF-36: 𝑃 =
0.018) and a significant reduction in perceived stress (PSS:
𝑃 = 0.027) from baseline to follow-up assessment.
Analyses examining immediate effects of the two
WATSU-treatments on participants’ level of stress, pain, and
mood consistently showed significant improvements in all
outcome measures (see Table 3; for individualized stress
curves see Figure 2).
In contrast to the control group, participants in the inter-
vention group reported significant decreases in perceived
stress from day 1 to day 8 whereas no significant group differ-
enceswere found formean change values of SF-36main scales
(see Table 4). Short term effects of WATSU on stress, pain,
and mood that were observed within the intervention group
were also present in comparison to the control group (see
Table 5).
Data from ultrasound examinations in the intervention
group revealed normal amounts of amniotic fluid with
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Figure 2: Changes in perceived stress measured by VAS (Visual
Analog Scale; higher scores indicate increased stress, maximum
score: 10).
respect to the gestational age, that is, >2 cm and <8 cm at the
single deepest amniotic fluid pocket (SDP) [38, 39] at base-
line, before and after each WATSU treatment, and at follow-
up (day 8) for all participants of the intervention group. Four
participants with low baseline values (≤3.8 cm,mean 3.6 cm±
0.1 cm) showed an average increase in amniotic fluid to
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Table 2: Analyses of medium-term changes in psychometric outcome measures within the intervention group.
Variablesa At baseline (day 1) At follow-up (day 8) Δ value 𝑃b
PSS scorec 14.8 (±5.0) 12.7 (±5.3) −2.1 (±2.2) 0.027∗
SF-36 main scalesd
(i) Physical component 47.0 (±6.8) 45.3 (±11.0) −1.7 (±6.7) 0.735
(ii) Mental component 46.4 (±11.6) 50.0 (±12.3) +3.3 (±4.0) 0.018∗
SF-36 sub scalesd
(i) Physical function 58.9 (±11.4) 61.1 (±18.7) +2.2 (±10.9) 0.527
(ii) Role physical 72.2 (±49.1) 66.7 (±43.3) −5.6 (±48.1) 1.00
(iii) Bodily pain 72.7 (±49.2) 70.4 (±26.3) −2.2 (±4.1) 0.157
(iv) General health 81.3 (±10.8) 79.7 (±17.4) −2.4 (±13.8) 0.786
(v) Vitality 50.6 (±18.3) 55.6 (±18.3) +5.0 (±9.0) 0.114
(vi) Social function 76.4 (±22.1) 79.2 (±21.7) +2.8 (±8.3) 0.317
(vii) Role emotional 63.0 (±38.9) 70.4 (±38.9) +7.4 (±22.2) 0.317
(viii) Mental health 67.1 (±16.9) 72.0 (±18.6) +4.9 (±8.4) 0.125
aAll continuous data are presented as mean (±SD).
b
𝑃 values refer to Wilcoxon test. ∗P > 0.05; CI 95%.
cPSS, Perceived Stress Scale; positive mean change values represent an increase in perceived stress.
dSF-36, Medical Outcomes Study 36-Item Short-Form Health Survey; positive mean change values represent an increase in health related quality of life.
Table 3: Analyses of short-term changes in psychometric outcome measures within the intervention group.
Variablesa Before WATSU After WATSU Δ value 𝑃b
VAS stressfulness (mm)c
(i) At day 1 27 (±28) 5 (±9) −21 (±22) 0.028∗
(ii) At day 4 16 (±15) 2 (±2) −14 (±14) 0.012∗
VAS pain (mm)c
(i) At day 1 9 (±12) 2 (±3) −8 (±9) 0.028∗
(ii) At day 4 12 (±10) 1 (±1) −11 (±11) 0.012∗
MDMQmood scale scored
(i) At day 1 16.9 (±2.8) 18.7 (±2.6) +1.8 (±1.9) 0.042∗
(ii) At day 4 14.7 (±6.8) 19.3 (±1.0) +4.7 (±6.2) 0.027∗
MDMQ alertness scale scored
(i) At day 1 13.9 (±3.2) 16.0 (±2.4) +2.1 (±3.6) 0.122
(ii) At day 4 10.7 (±5.0) 16.3 (±2.4) +5.7 (±4.7) 0.007∗
MDMQ calmness scale scored
(i) At day 1 13.7 (±3.0) 18.0 (±2.9) +4.3 (±3.0) 0.012∗
(ii) At day 4 12.8 (±5.6) 18.3 (±1.7) +5.6 (±5.8) 0.015∗
aAll continuous data are presented as mean (±SD).
b
𝑃 values refer to Wilcoxon test. ∗𝑃 > 0.05; CI 95%.
cVAS, Visual Analog Scale; positive mean change values represent an increase in actual stress (actual pain).
dMDMQ, Multidimensional-Mood-Questionnaire; positive mean change values represent an increase in mood, alertness, and calmness.
5.9 cm ± 1.5 cm on day 8. For one participant, the values
remained practically unchanged (from 5.5 cm to 5.6 cm), and
in four cases that presented values ≥5.6 cm (6.8 cm ± 0.8 cm)
at baseline, the amniotic fluid value decreased to amean value
of 5.02 cm ± 0.7 cm (see Figure 3).
Similarly, the pulsatility indexes (PI) obtained from the
umbilical artery and from both maternal vessels were within
normal ranges for the respective gestational age and no
significant changes were observed comparing pre- and post-
treatment values (𝑃 values ≥ 0.23). No signs of adverse reac-
tions were detectable in ultrasound measures at any point in
the study.
3
4
5
6
7
8
Day 1 Day 8
SD
P 
(c
m
)
Figure 3: Changes in the amount of amniotic fluid in centimeter
in the intervention group measured at the SDP (single deepest
amniotic fluid pocket).
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Table 4: Analyses of medium-term changes in outcome measures between the intervention and the control group.
Variablesa
Δ values
𝑃
b Cohen’s 𝑓From baseline (day 1) to follow-up (day 8)
Intervention group Control group
PSS scorec −2.1 (±2.2) +.9 (±3.2) 0.036∗ 0.57
SF-36 main scalesd
(i) Physical component −1.6 (±6.6) +.2 (±6.4) 0.500
(ii) Mental component +3.3 (±4.0) +3.1 (±3.6) 0.923
aAll continuous data are presented as mean (SD).
b
𝑃 values refer to Mann-Whitney test. ∗P > 0.05; CI 95%.
cPSS, Perceived Stress Scale; positive mean change values represent an increase in perceived stress.
dSF-36, Medical Outcomes Study 36-Item Short-Form Health Survey; positive mean change values represent an increase in health related quality of life.
Table 5: Analyses of short-term changes in outcome measures between the intervention and the control group.
Variablesa
Δ values
𝑃
b Cohen’s 𝑓Intervention group before
and after WATSU
Control group before and
after 2 hours waiting
period
VAS stressfulness (mm)c
(i) At day 1 −21 (±22) −3 (±11) 0.090
(ii) At day 4 −14 (±14) +1 (±12) 0.021∗ 0.61
VAS pain (mm)c
(i) At day 1 −8 (±9) −1 (±4) 0.037∗ 0.51
(ii) At day 4 −11 (±11) +3 (±10) 0.005∗ 0.72
MDMQmood scale scored
(i) At day 1 +1.8 (±1.9) +0.5 (±2.51) 0.175
(ii) At day 4 +4.7 (±6.2) −0.1 (±1.13) 0.013∗ 0.56
MDMQ alertness scale scored
(i) At day 1 +2.1 (±3.6) +0.1 (±1.2) 0.200
(ii) At day 4 +5.7 (±4.7) +0.4 (±1.2) 0.001∗ 0.79
MDMQ calmness scale scored
(i) At day 1 4.6 (±3.0) −0.3 (±1.9) 0.002∗ 0.96
(ii) At day 4 5.6 (±5.8) −0.5 (±2.2) 0.008∗ 0.71
aAll continuous data are presented as mean (SD).
b
𝑃 values refer to Mann-Whitney test. ∗P > 0.05; CI 95%.
cVAS, Visual Analog Scale; positive mean change values represent an increase in actual stress (actual pain).
dMDMQ, Multidimensional-Mood-Questionnaire; positive mean change values represent an increase in mood, alertness, and calmness.
Due to optimal tonus of the uterus, four of the partici-
pants in the intervention group underwent cephalic version
on day 9 of the study, with two attempts being successful. Of
the eight fetuses in breech position in the intervention group,
one spontaneously presented in cephalic position on day 4.
The two fetuses in breech in the control group remained in
this position up to day 8 and one attempt for cephalic version
failed.
3.2. Qualitative Results. A total of 57 comments reflecting
subjective perceptions of the intervention were obtained
from nine participants and were classified into main and
subcategories as presented in Table 6.
Relaxation was most frequently reported as a major
overall impression of the WATSU-treatments but was also
distinctly mentioned by participants as an effect of treatment
on their physical and mental states. Participants shared
observations regarding body-related changes, for example,
regained mobility and flexibility and decreased pain. They
empathically reflected on how this experience might be per-
ceived by their unborn children and on the nature of jointly
experiencing an aquatic environment. Some of the women
expressed gratitude for having been able to participate in the
study and emphasized their impressions of having learned
something about relaxation and surrendering that they per-
ceived as a very helpful preparation for the upcoming birth.
The intervention was referred to using positive descriptions
such as “like a dream.” Mind-related aspects represented the
majority (26.3%) of comments. All participants described
WATSU as an experience they had fully enjoyed, and the
opportunity to suggest improvements was instead used to
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Table 6: Results from analysis of qualitative data reflecting participants’ perception of the intervention.
Categories Mentions (𝑛 = 60) Sample phrases
In absolute values In % values
(1) Overall impression 12 21.1
(1.1) Overall relaxation 8 14.0 “Total relaxation!”
(1.2) Overall positive impression 4 7.0 “Very pleasant!”
(2) Body related 10 17.5
(2.1) Physical relaxation 4 7.0 “I think my belly relaxed too.”
(2.2) Mobilization 2 3.5 “My lower back and the right side of the trunk are loosened.”
(2.3) Transfer to daily life 2 3.5 “Walking became easier.”
(2.4) Weightlessness 1 1.8 “It is great to feel light and weightless once in a while during pregnancy!”
(2.5) Reduction of pain 1 1.8 “Less pain.”
(3) Mind related 15 26.3
(3.1) Perception 6 10.5 “No distractions since ears were underneath the surface.”
(3.2) Peace of mind 4 7.0 “Free of thoughts and fears.”
(3.3) Learning 3 5.3 “Ideal preparation for birth.”
(3.5) Focus on breech position 2 3.5 “My child moved a lot but did not turn.”
(4) Child related 10 17.5
(4.1) Child relaxed 2 3.5 “After a while, my child relaxed with me.”
(4.2) Child active 5 8.8 “I felt my child moving a lot.”
(4.3) Interpretation of child’s feeling 1 1.8 “The baby liked it too; she was very quiet.”
(4.4) Contact to child 2 3.5 “I think it is a good way to come close to the child—both are in water.”
(5) Further suggestions 10 17.5
(5.1) Improvements 4 7.0 “Start WATSU earlier in pregnancy.”
(6.1) Emphasizing satisfaction 6 10.5 “There was nothing I disliked; everything was just great.”
emphasize satisfaction by six participants. The four stated
suggestions concerning technical and process-related aspects
of the study involved timing issues such as delays in ultra-
sound examination as well as a lack of clarity about where to
hand in feedback-forms. One person mentioned a WATSU
treatment-specific observation (having felt uncomfortable
with hip flexion), and one woman suggested startingWATSU
treatment earlier in pregnancy.
4. Discussion
Active aquatic therapies have been studied extensively and
proven to be beneficial for pregnant women [25]. Since
passive hydrotherapy was not yet scientifically investigated
with respect to its effects on pregnant women, we conducted a
controlled pilot study to investigate the effects of WATSU on
women in their ≥34th week of gestation, as well as to evaluate
which of the investigated parameters would be suitable
outcome measurements for further large-scale clinical trials.
As the impacts of maternal stress on unborn children
can be severe [1–5], interventions that effectively reduce
stress during pregnancy are desirable. Significant short-
term improvements measured with VAS and MDMQ and
significant medium-term decreases in perceived stress (PSS),
with respective increases in the mental component of SF-36
main scale, indicate an optimized situation concerning the
emotional wellbeing of the participants in the intervention
group. Components of WATSU including gentle touch are
believed to act in a stress reducing manner [40, 41]. In
addition, the therapist’s thoroughly compassionate attitude
allows her/him to enter a parasympathetic state that the
patient is nonverbally encouraged to join in [42]. During
immersion, patients experience decreased heart rates [18] that
are organically anticipating andpromoting a parasympathetic
state of relaxation. Reduced hypothalamic-pituitary-adrenal
axis activity, that is, lower plasma cortisol levels along with
increased mental and physical relaxation in context with
immersion, has previously been reported [43, 44]. A potential
mode of action promoting emotional wellbeing might be the
activation of afferent C-tactile fibers during immersion. It has
been proposed that these fibers transmit slow gentle touch—
analogous to bypassing water—that has been observed to
activate emotional brain areas [45, 46].
Short-term effects on pain were significant in our study
(see Tables 3 and 5). This is of clinical relevance as epi-
demiological data indicate that two out of three pregnant
women suffer pregnancy-related low back pain [22]. During
pregnancy, it is recommended to refrain from analgesics [47],
and thus nonpharmacologic alternatives are desirable. Prior
research found that merely being immersed in warm water
decreases pain [44, 48]. Passive hydrotherapy offers in addi-
tion unique possibilities of weightless mobilization in a quasi
gravity-free environment with reduced joint compression
forces. This in turn creates turbulence and currents causing
a sensory overflow, which is regarded as one mechanism in
pain reduction following immersion [17]. According to expert
opinion, WATSU might be alleviating excessive muscle tone
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and pain due to rotationalmovements of the trunk and gentle
rocking of the whole body, leading to dampened muscle tone
as a side effect of vestibular system activation [49].
Neither the amniotic fluid volume nor umbilical blood
flow characteristics were significantly altered after WATSU
treatment. Although the sample size is small and therefore
generalizability of the results has to be taken carefully, no
adverse maternal and fetal reactions have been observed.The
examining gynecologists perceived the tone of the uterus as
being lower after WATSU treatment, encouraging them to
emphatically suggest external cephalic version in four cases.
Their observations might be evaluated objectively by elec-
tromyogram (EMG) in future studies. Breech presentation is
a complication that occurs in only 3-4% of pregnancies but is
a very real threat to the mother’s as well as the child’s life [50].
External cephalic version to correct the child’s position is
being suggested although associated with risks for mother
and child [51, 52].The success rate of external cephalic version
attempts is strongly dependent on uterine tension (OR 18;
95% CI, 12–29) [53] and to a lesser extent also on the amount
of amniotic fluid [54].
Only 10% of the amniotic fluid is regulated by transmem-
branous processes while intra-amniotic interactions—mainly
fetal urine production, swallowing, and fluid secretions from
the respiratory tract—regulate 90% [55, 56]. However, four
participants showed slight increases in SDP measurements
from day 1 to day 8. We also measured decreases in amniotic
fluid over the period of seven days, which stands in contrast to
the findings described in the literature [55, 57]. Since no for-
malized guidelines for the management of polyhydramnion
exist to date [38], the decrease of amniotic fluid due to immer-
sionmight be a findingwarranting further exploration.While
short-term changes in the amount of amniotic fluid due to
immersion were observed to be equalized within 30 minutes
after immersion [58], the changes observed in our study took
place over a longer period of time andwould therefore suggest
the involvement of respective regulatory processes.
Perceived relaxation and pleasantness seem to be among
the most obvious features of passive hydrotherapy and were
mentioned by participants in this study with great consis-
tency in qualitative feedback. Interestingly, WATSU, despite
its massage character, was attributed to mental effects most
frequently. It appears to have been perceived by our partici-
pants rather as a mind-body-intervention, particularly suit-
able to inviting serenity as well as broadened awareness and
mindfulness. Comments suggest usefulness of WATSU not
only at the third trimester of pregnancy, but also in earlier
stages, for example, potentially supporting women in over-
coming ambivalence with respect to their motherhood.
5. Limitations
The following limitations of this study need to be addressed.
The original study design implied ultrasound examinations
on the control group as well to assess the natural course of
changes in the amount of amniotic fluid [59]. In fact, only one
woman in the control group agreed to follow this procedure.
Also blinding of any party but the statistician is a challenge.
Most of the mothers-to-be in our intervention group
learned about the diagnosis of breech presentation a short
time before their enrollment and were thus suddenly being
confronted with decisions about whether or not to undergo
external cephalic version or cesarean section. In this respect,
they differed considerably from participants in the control
group, who represented a more general population. It is
therefore unclear, to what extent specifically the medium-
term effects of emotional recovery can be attributed to the
treatment.
A small sample sizemay lead to the identification of large,
clinically relevant effects; however, selection bias and overly
weighted outliers cannot be ruled out. Hence, caution is
appropriate when interpreting the present results. Due to the
small sample size, we were not able to definitively interpret
all of our findings scientifically, particularly the impact of
WATSU treatment on spontaneous versions of children in
breech position.
In qualitative data, saturation might have been achieved
in terms of categories; however, since several aspects were
mentioned only once, there might have been additional new
statements concerning the experience, had more individuals
participated in the survey.
6. Conclusions
To our knowledge, this is the first clinical study investigating
the effects of passive hydrotherapy during pregnancy. It
demonstrates significant benefits of WATSU with respect to
stress, pain, mood, and mental health-related quality of life.
Apparently, lowered tone of the uterus encouraged attempts
of cephalic versions when children were in breech position.
The treatment was described as very agreeable by the partic-
ipants and appears to be a safe intervention.
These findings support the notion that WATSU yields
therapeutic benefits for pregnant women; therefore, its inte-
gration into interdisciplinary treatment approaches should be
considered.On the basis of this pilot study, larger trials should
be established to further investigate and confirm the impact
of the observed effects.
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